Exactech Goes Private in $625M Deal With TPG Capital Post author:Sam Post published:October 22, 2017 Post category:BioPharma TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace You Might Also Like Top 9 Biotech Giants to Work for in New Jersey July 5, 2017 ImmunoCellular Therapeutics To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 March 6, 2017 Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC September 14, 2017
ImmunoCellular Therapeutics To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 March 6, 2017